The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
NCT ID: NCT02156024
Last Updated: 2014-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
400 participants
INTERVENTIONAL
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To determine whether the Gastrodia and Uncaria Drink is effective in the treatment of masked hypertensive patients below 70 years.
2. To find out the suitable groups for the Gastrodia and Uncaria Drink treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study
NCT04035824
Effects of Hoodia on Blood Pressure and Heart Function
NCT00693264
Standardized Eucommia Extract in the Treatment of Hypertension
NCT00626132
Investigating the Role of Ginger Tea ORAC Value in Hypertension Management
NCT06762834
Anti-hypertensive Effect of Mycelia of Antrodia Cinnamomea
NCT02532699
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
placebo drink, 1 dose at a time, twice a day, duration: 4 weeks
No interventions assigned to this group
Gastrodia and Uncaria Drink
Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 4 weeks
Gastrodia and Uncaria Drink
Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gastrodia and Uncaria Drink
Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 4 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* didn't use any anti-hypertension drugs within 2 weeks
* stage 1 masked hypertensive patients, which means clinic blood pressure\<140/90 mmHg,however the daytime(8:00-18:00) 24h ambulatory blood pressure between 135/85 and 150/95mmHg
* be willing to participate in the trials and able to finish clinic visit
Exclusion Criteria
* be allergic to the clinical trial medicine
* occurrence of stroke, CKD, myocardial infarction within 2 years
* dysfunction of liver or kidney and fundus hemorrhage
* arrhythmia
* ALT, AST, TBL upper the twice of normal range, Scr≥2.0mg/dl, K+≥5.5mmol/L, Urine protein≥2+
* psychiatric disorders
* pregnant, breastfeeding
* other serious conditions in which is not fit for the study
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Institute of Hypertension
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cheng Yibang
master
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruijin Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang DY, Cheng YB, Guo QH, Shan XL, Wei FF, Lu F, Sheng CS, Huang QF, Yang CH, Li Y, Wang JG. Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial. Circulation. 2020 Nov 10;142(19):1821-1830. doi: 10.1161/CIRCULATIONAHA.120.046685. Epub 2020 Oct 6.
Wei FF, Li Y, Zhang L, Shan XL, Cheng YB, Wang JG, Yang CH, Staessen JA. Persistence of Masked Hypertension in Chinese Patients. Am J Hypertens. 2016 Mar;29(3):326-31. doi: 10.1093/ajh/hpv106. Epub 2015 Jul 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JDZX2012115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.